Ning Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ning Wang has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Baohua Wang
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
3 shared publicationsChangqiong Wang
Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2 shared publicationsFeng J He
Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
2 shared publicationsJing Fan
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
2 shared publications- Liwen Fang
National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Xicheng District, Beijing, 100050, China
2 shared publications - Puhong Zhang
Food Policy Division, The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia
2 shared publications
Latest Publications
- Open Access
Risk factors for cancer among the working population in China: a cross-sectional analysis of baseline data from the WECAN project
Objective: This study aims to assess the prevalence of cancer risk factors in China’s working population and provide evidence for formulating more targeted workplace cancer prevention strategies. Design: A cross-sectional study utilising the baseline data from the Comprehensive Workplace Intervention for Cancer Prevention in China (WECAN) project, a stepped-wedge cluster randomised controlled trial. Setting: 15 workplaces from three cities in China: Wuhai (Northern China), Nanchong (Western China) and Xiangtan (Southern China). Participants: A total of 841 participants (56 employees per workplace) were recruited through stratified sampling based on sex and work type. Primary outcome measures: The prevalence of self-reported cancer risk factors, including smoking, alcohol consumption, physical inactivity, obesity, unhealthy diet, betel quid chewing, exposure to harmful gases or substances, biological screening and vaccination. Results: The study included 841 participants (mean age 40.5±8.9 years; 61.4% male, 57.4% blue-collar workers, 47.3% aged <40 years), with 36.4% reporting family cancer history. The reported cancer risks included smoking (36.9%, male–female OR=40.4 (95% CI 21.6 to 75.7)), alcohol consumption (63.6%, male–female OR=4.3 (95% CI 3.0 to 6.0)), physical inactivity (49.1%), central obesity (36.7%, male–female OR=3.2 (95% CI 2.3 to 4.5)), unhealthy diet (95.8% with two or more of six unhealthy dietary habits), betel quid chewing (18.8%, male–female OR=3.3 (95% CI 1.9 to 5.9), with 97.5% in Xiangtan), preference for hot foods (5.0%, older–younger OR=2.5 (95% CI 1.1 to 5.6)), household air pollution (7.0%, higher risk among lower-educated individuals), unprotected occupational exposure (6.1%, male–female OR=2.8 (95% CI 1.3 to 6.0), blue-white collar OR=2.1 (95% CI 1.0 to 4.5)), no screening for hepatitis B surface antigen (46.4%) and helicobacter pylori (54.9%), and unvaccinated against hepatitis B virus (28.1%) and human papillomavirus (63.5% among females≤45 years). Regional heterogeneity was observed for nearly all risk factors. Conclusions: The working population faces significant cancer risk factors, with variations across populations and regions highlighting the need for targeted interventions. Trial registration number: ChiCTR2200058680.
Open AccessRisk factors for cancer among the working population in China: a cross-sectional analysis of baseline data from the WECAN project
Objective: This study aims to assess the prevalence of cancer risk factors in China’s working population and provide evidence for formulating more targeted workplace cancer prevention strategies. Design: A cross-sectional study utilising the baseline data from the Comprehensive Workplace Intervention for Cancer Prevention in China (WECAN) project, a stepped-wedge cluster randomised controlled trial. Setting: 15 workplaces from three cities in China: Wuhai (Northern China), Nanchong (Western China) and Xiangtan (Southern China). Participants: A total of 841 participants (56 employees per workplace) were recruited through stratified sampling based on sex and work type. Primary outcome measures: The prevalence of self-reported cancer risk factors, including smoking, alcohol consumption, physical inactivity, obesity, unhealthy diet, betel quid chewing, exposure to harmful gases or substances, biological screening and vaccination. Results: The study included 841 participants (mean age 40.5±8.9 years; 61.4% male, 57.4% blue-collar workers, 47.3% aged <40 years), with 36.4% reporting family cancer history. The reported cancer risks included smoking (36.9%, male–female OR=40.4 (95% CI 21.6 to 75.7)), alcohol consumption (63.6%, male–female OR=4.3 (95% CI 3.0 to 6.0)), physical inactivity (49.1%), central obesity (36.7%, male–female OR=3.2 (95% CI 2.3 to 4.5)), unhealthy diet (95.8% with two or more of six unhealthy dietary habits), betel quid chewing (18.8%, male–female OR=3.3 (95% CI 1.9 to 5.9), with 97.5% in Xiangtan), preference for hot foods (5.0%, older–younger OR=2.5 (95% CI 1.1 to 5.6)), household air pollution (7.0%, higher risk among lower-educated individuals), unprotected occupational exposure (6.1%, male–female OR=2.8 (95% CI 1.3 to 6.0), blue-white collar OR=2.1 (95% CI 1.0 to 4.5)), no screening for hepatitis B surface antigen (46.4%) and helicobacter pylori (54.9%), and unvaccinated against hepatitis B virus (28.1%) and human papillomavirus (63.5% among females≤45 years). Regional heterogeneity was observed for nearly all risk factors. Conclusions: The working population faces significant cancer risk factors, with variations across populations and regions highlighting the need for targeted interventions. Trial registration number: ChiCTR2200058680.
- Open Access
- 1 September 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 18 (5) , 059511
Corrigendum: Research on the inhibition for aseptic loosening of artificial joints by Sr-doped calcium polyphosphate (SCPP) in vivo (2021 Biomed. Mater. 16 065017)
- 1 September 2023
- Published by IOP Publishing in Biomedical Materials
- Vol. 18 (5) , 059511
Open AccessCorrigendum: Research on the inhibition for aseptic loosening of artificial joints by Sr-doped calcium polyphosphate (SCPP) in vivo (2021 Biomed. Mater. 16 065017)
- Open Access
Comprehensive workplace intervention for cancer prevention in China (WECAN): protocol for a stepped-wedge, cluster-randomised controlled trial
Introduction Cancer is the second leading cause of death across the globe with the majority of deaths occurring in low-income and middle-income countries. Evidence has shown that the cancer burden can be substantially reduced by avoiding behavioural risk factors through comprehensive intervention strategies, including workplace health promotion, which has shown to be cost-effective in developed countries while rarely conducted in developing countries. This study aims to explore a feasible and sustainable approach to the prevention and control of cancer in China by developing an evidence-based comprehensive workplace health model equipped with a smartphone application for implementation. Methods and analysis This study is designed as a stepped-wedge, cluster-randomised controlled trial. We will recruit 15 workplaces from three cities in China. A total of 750 employees will be randomly selected for evaluation that includes five rounds of survey conducted every 6 months. After the second evaluation, workplaces will be randomly allocated to start the intervention sequentially every 6 months in three steps with five workplaces per step. A mobile application ‘Healthy Workplace’ will be developed to support the intervention. On-line and off-line health-related activities will be carried out among employees. Employers will provide supportive policies, environment and benefits to facilitate the adoption of healthy behaviours. The primary outcome is the change of Healthy Lifestyle Index Score, which consists of five components including smoking, alcohol drinking, physical activity, diet and body mass index. Ethics and dissemination The study has been approved by Queen Mary University of London Ethics of Research Committee (QMERC22.257) and Chinese Centre for Disease Control and Prevention Institutional Review Board (202210). Written informed consent is required from all participants. Results will be disseminated through presentations, publications and social media. Trial registration number ChiCTR2200058680.
Open AccessComprehensive workplace intervention for cancer prevention in China (WECAN): protocol for a stepped-wedge, cluster-randomised controlled trial
Introduction Cancer is the second leading cause of death across the globe with the majority of deaths occurring in low-income and middle-income countries. Evidence has shown that the cancer burden can be substantially reduced by avoiding behavioural risk factors through comprehensive intervention strategies, including workplace health promotion, which has shown to be cost-effective in developed countries while rarely conducted in developing countries. This study aims to explore a feasible and sustainable approach to the prevention and control of cancer in China by developing an evidence-based comprehensive workplace health model equipped with a smartphone application for implementation. Methods and analysis This study is designed as a stepped-wedge, cluster-randomised controlled trial. We will recruit 15 workplaces from three cities in China. A total of 750 employees will be randomly selected for evaluation that includes five rounds of survey conducted every 6 months. After the second evaluation, workplaces will be randomly allocated to start the intervention sequentially every 6 months in three steps with five workplaces per step. A mobile application ‘Healthy Workplace’ will be developed to support the intervention. On-line and off-line health-related activities will be carried out among employees. Employers will provide supportive policies, environment and benefits to facilitate the adoption of healthy behaviours. The primary outcome is the change of Healthy Lifestyle Index Score, which consists of five components including smoking, alcohol drinking, physical activity, diet and body mass index. Ethics and dissemination The study has been approved by Queen Mary University of London Ethics of Research Committee (QMERC22.257) and Chinese Centre for Disease Control and Prevention Institutional Review Board (202210). Written informed consent is required from all participants. Results will be disseminated through presentations, publications and social media. Trial registration number ChiCTR2200058680.
- 17 June 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 10, 200-204
A Reasoning Method of Electronic Evidence in Judicial Practice
Electronic evidence has become a kind of important evidence in lawsuits but the rate of adopted electronic evidence is not high in the court. The reason is that the high technologies of electronic evidenc brings about the confusion of judgement. In this paper, we put forward a formalized reasoning framework and the algorithm of electronic evidence proceeding, and discuss their analytical process combined with the network fraud cases as an example. The current practice shows the mothod is feasible and has a consulting value in analyzing the electronic evidence proceeding in judicial practice.
- 17 June 2022
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 10, 200-204
A Reasoning Method of Electronic Evidence in Judicial Practice
Electronic evidence has become a kind of important evidence in lawsuits but the rate of adopted electronic evidence is not high in the court. The reason is that the high technologies of electronic evidenc brings about the confusion of judgement. In this paper, we put forward a formalized reasoning framework and the algorithm of electronic evidence proceeding, and discuss their analytical process combined with the network fraud cases as an example. The current practice shows the mothod is feasible and has a consulting value in analyzing the electronic evidence proceeding in judicial practice.
- Open Access
- 27 July 2021
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 28 (10) , 1464-1473
Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, China
Yichang is a city in central China in the Hubei Province. This study aimed to estimate the dynamics of the transmissibility of hepatitis C using a mathematical model and predict the transmissibility of hepatitis C in 2030. Data of hepatitis C cases from 13 counties or districts (cities) in Yichang from 2008 to 2016 were collected. A Susceptible-Infectious-Chronic-Recovered (SICR) model was developed to fit the data. The transmissibility of hepatitis C at the counties or districts was calculated based on new infections (including infected or chronically infected cases) reported monthly in the city caused by one infectious individual (MNI). The trend of the MNI was fitted and predicted using 11 models, with the coefficient of determination (R2) was being used to test the goodness of fit of these models. A total of 3065 cases of hepatitis C were reported in Yichang from 2008 to 2016. The median MNI of Yichang was 0.0768. According to the fitting results and analysis, the trend of transmissibility of hepatitis C in Yichang City conforms with the Logarithmic (R2 = 0.918, P < 0.001):MNI = 0.265 – 0.108log(t), and Exponential (R2 = 0.939, P < 0.001):MNI = 0.344е(-0.278t) models. Hence, the transmission of hepatitis C virus at the county level has a downward trend. In conclusion, the transmissibility of hepatitis C in Yichang has a downward trend. With the current preventive and control measures in place, the spread of hepatitis C can be controlled.
- 27 July 2021
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 28 (10) , 1464-1473
Open AccessEstimating the transmissibility of hepatitis C: A modelling study in Yichang City, China
Yichang is a city in central China in the Hubei Province. This study aimed to estimate the dynamics of the transmissibility of hepatitis C using a mathematical model and predict the transmissibility of hepatitis C in 2030. Data of hepatitis C cases from 13 counties or districts (cities) in Yichang from 2008 to 2016 were collected. A Susceptible-Infectious-Chronic-Recovered (SICR) model was developed to fit the data. The transmissibility of hepatitis C at the counties or districts was calculated based on new infections (including infected or chronically infected cases) reported monthly in the city caused by one infectious individual (MNI). The trend of the MNI was fitted and predicted using 11 models, with the coefficient of determination (R2) was being used to test the goodness of fit of these models. A total of 3065 cases of hepatitis C were reported in Yichang from 2008 to 2016. The median MNI of Yichang was 0.0768. According to the fitting results and analysis, the trend of transmissibility of hepatitis C in Yichang City conforms with the Logarithmic (R2 = 0.918, P < 0.001):MNI = 0.265 – 0.108log(t), and Exponential (R2 = 0.939, P < 0.001):MNI = 0.344е(-0.278t) models. Hence, the transmission of hepatitis C virus at the county level has a downward trend. In conclusion, the transmissibility of hepatitis C in Yichang has a downward trend. With the current preventive and control measures in place, the spread of hepatitis C can be controlled.
- Open Access
- 1 June 2021
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 31 (1) , 1-8
Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study
This study aims to investigate the characteristics of the phenotype and management of chronic obstructive pulmonary disease (COPD) patients in the general population in China. We analyzed spirometry-confirmed COPD patients who were identified from a population-based, nationally representative sample in China. All participants were measured with airflow limitation severity based on post-bronchodilator FEV1 percent predicted, bronchodilator responsiveness, exacerbation history, and respiratory symptoms. Among a total of 9134 COPD patients, 90.3% were non-exacerbators, 2.9% were frequent exacerbators without chronic bronchitis, 2.0% were frequent exacerbators with chronic bronchitis, and 4.8% were asthma-COPD overlap. Less than 5% of non-exacerbators ever had pulmonary function testing performed. The utilization rate of inhaled medication in non-exacerbators, exacerbators without chronic bronchitis, exacerbators with chronic bronchitis, and asthma-COPD overlap was 1.4, 23.5, 29.5, and 19.4%, respectively. A comprehensive strategy for the management of COPD patients based on phenotype in primary care is urgently needed.
- 1 June 2021
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 31 (1) , 1-8
Open AccessPhenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study
This study aims to investigate the characteristics of the phenotype and management of chronic obstructive pulmonary disease (COPD) patients in the general population in China. We analyzed spirometry-confirmed COPD patients who were identified from a population-based, nationally representative sample in China. All participants were measured with airflow limitation severity based on post-bronchodilator FEV1 percent predicted, bronchodilator responsiveness, exacerbation history, and respiratory symptoms. Among a total of 9134 COPD patients, 90.3% were non-exacerbators, 2.9% were frequent exacerbators without chronic bronchitis, 2.0% were frequent exacerbators with chronic bronchitis, and 4.8% were asthma-COPD overlap. Less than 5% of non-exacerbators ever had pulmonary function testing performed. The utilization rate of inhaled medication in non-exacerbators, exacerbators without chronic bronchitis, exacerbators with chronic bronchitis, and asthma-COPD overlap was 1.4, 23.5, 29.5, and 19.4%, respectively. A comprehensive strategy for the management of COPD patients based on phenotype in primary care is urgently needed.
Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017
Background: China's lung cancer (LC) burden plays a pivotal role in the global cancer epidemic. Comparing LC burden and population attributable fractions (PAFs) of risk factors between China and other countries/regions is essential to inform effective intervention. The Global Burden of Disease (GBD) study provides a unique opportunity for such comparisons.Methods: We extracted the number of LC deaths, age‐standardized death rates (ASDRs), age‐standardized disability‐adjusted life‐year (DALY) rates, and PAFs of risk factors for LC deaths between 1990 and 2017 from GBD 2017. The annual percentage change (APC) was used to quantify the trends of LC ASDRs and age‐standardized DALY rates. The relationship between the APC of LC ASDR and Socio‐demographic Index was assessed among China and other countries.Results: Globally, the ASDR for LC decreased in men (APC, −0.66% [95% CI, −0.69 to −0.62]) but increased in women (APC, 0.31% [95% CI, 0.26 to 0.36]) from 1990 to 2017. The ASDRs in China increased both for men (APC, 1.12% [95% CI, 1.03 to 1.20]) and women (APC, 0.80% [95% CI, 0.70 to 0.89]). The increased LC death numbers among men (312,798) and women (139,115) in China accounted for 59.39% and 43.01% of global increases. LC years of life lost accounted for the majority of LC DALYs globally and in China. The risk factors with the highest PAFs of LC death in China were smoking and ambient particulate matter. The ASDRs for LC associated with ambient particulate matter in China ranked second globally.Conclusions: The trends of LC ASDRs and age‐standardized DALY rates and the PAFs of risk factors vary markedly by region, indicating a need for tailored measures to reduce LC burden and improve health equality. China's LC ASDRs are among the highest in the world, and the primary intervention priorities in China should be control of ambient particulate matter and tobacco usage.
Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017
Background: China's lung cancer (LC) burden plays a pivotal role in the global cancer epidemic. Comparing LC burden and population attributable fractions (PAFs) of risk factors between China and other countries/regions is essential to inform effective intervention. The Global Burden of Disease (GBD) study provides a unique opportunity for such comparisons.Methods: We extracted the number of LC deaths, age‐standardized death rates (ASDRs), age‐standardized disability‐adjusted life‐year (DALY) rates, and PAFs of risk factors for LC deaths between 1990 and 2017 from GBD 2017. The annual percentage change (APC) was used to quantify the trends of LC ASDRs and age‐standardized DALY rates. The relationship between the APC of LC ASDR and Socio‐demographic Index was assessed among China and other countries.Results: Globally, the ASDR for LC decreased in men (APC, −0.66% [95% CI, −0.69 to −0.62]) but increased in women (APC, 0.31% [95% CI, 0.26 to 0.36]) from 1990 to 2017. The ASDRs in China increased both for men (APC, 1.12% [95% CI, 1.03 to 1.20]) and women (APC, 0.80% [95% CI, 0.70 to 0.89]). The increased LC death numbers among men (312,798) and women (139,115) in China accounted for 59.39% and 43.01% of global increases. LC years of life lost accounted for the majority of LC DALYs globally and in China. The risk factors with the highest PAFs of LC death in China were smoking and ambient particulate matter. The ASDRs for LC associated with ambient particulate matter in China ranked second globally.Conclusions: The trends of LC ASDRs and age‐standardized DALY rates and the PAFs of risk factors vary markedly by region, indicating a need for tailored measures to reduce LC burden and improve health equality. China's LC ASDRs are among the highest in the world, and the primary intervention priorities in China should be control of ambient particulate matter and tobacco usage.
- Open Access
- 2 July 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 617
C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
Objective: To explore the association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with risperidone-induced weight gain. Methods: We analyzed the association between MTHFR C677T polymorphism and risperidone-induced weight gain in 356 schizophrenia patients. The patients were treated with risperidone for 8 weeks. The height and body weight of the patients were measured before and 8 weeks after risperidone treatment. Blood DNA was genotyped for MTHFR C677T polymorphisms. Results: We found a significant association between MTHFR C677T polymorphism and body mass index (BMI) change after 8-week risperidone treatment. The BMI of carriers with different genotypes of MTHFR gene increased over 2–8 weeks. After 8 weeks of risperidone treatment, BMI added value (kg/m2) of CC or CT genotype carriers was significantly higher than that of TT genotype carriers [CC (4.47 ± 1.09), CT (4.54 ± 1.27), TT (2.31 ± 0.75), F = 5.634, P = 0.001]. Based on whether the rate of weight gain from baseline at 8 weeks of treatment exceeded 7%, it was divided into a weight gain group (n = 61) and a non-weight gain group (n = 295). The C allele frequency was significantly different between the two groups (48.4% vs 32.4%, χ2 = 11.342, P = 0.001). Conclusion: MTHFR C677T polymorphism was associated with risperidone-induced weight gain in Chinese Han population.
- 2 July 2020
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 11, 617
Open AccessC677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
Objective: To explore the association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with risperidone-induced weight gain. Methods: We analyzed the association between MTHFR C677T polymorphism and risperidone-induced weight gain in 356 schizophrenia patients. The patients were treated with risperidone for 8 weeks. The height and body weight of the patients were measured before and 8 weeks after risperidone treatment. Blood DNA was genotyped for MTHFR C677T polymorphisms. Results: We found a significant association between MTHFR C677T polymorphism and body mass index (BMI) change after 8-week risperidone treatment. The BMI of carriers with different genotypes of MTHFR gene increased over 2–8 weeks. After 8 weeks of risperidone treatment, BMI added value (kg/m2) of CC or CT genotype carriers was significantly higher than that of TT genotype carriers [CC (4.47 ± 1.09), CT (4.54 ± 1.27), TT (2.31 ± 0.75), F = 5.634, P = 0.001]. Based on whether the rate of weight gain from baseline at 8 weeks of treatment exceeded 7%, it was divided into a weight gain group (n = 61) and a non-weight gain group (n = 295). The C allele frequency was significantly different between the two groups (48.4% vs 32.4%, χ2 = 11.342, P = 0.001). Conclusion: MTHFR C677T polymorphism was associated with risperidone-induced weight gain in Chinese Han population.